Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties

Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity

(2013) Wei Xiang et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

The Targets of Curcumin

(2012) Hongyu Zhou et al.   CURRENT DRUG TARGETS

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

(2012) David N. Hauser et al.   NEUROBIOLOGY OF DISEASE

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

(2011) Tim Bartels et al.   NATURE

Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model

(2010) Min S Wang et al.   BMC NEUROSCIENCE

Differential protection of pre-, co- and post-treatment of curcumin against hydrogen peroxide in PC12 cells

(2010) MA Siddiqui et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells

(2010) Marina Pisano et al.   Molecular Cancer

Molecular Pathogenesis of Protein Misfolding Diseases: Pathological Molecular Environments Versus Quality Control Systems Against Misfolded Proteins

(2009) H. Naiki et al.   JOURNAL OF BIOCHEMISTRY

Inhibitory Effect of Dehydrozingerone on Vascular Smooth Muscle Cell Function

(2009) Yizhen Liu et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Are There Common Biochemical and Molecular Mechanisms Controlling Manganism and Parkisonism

(2009) Jerome A. Roth   NEUROMOLECULAR MEDICINE

Development of Novel Antiatherogenic Biaryls: Design, Synthesis, and Reactivity

(2008) Mélanie Delomenède et al.   JOURNAL OF MEDICINAL CHEMISTRY

Structural Characteristics of α-Synuclein Oligomers Stabilized by the Flavonoid Baicalein

(2008) Dong-Pyo Hong et al.   JOURNAL OF MOLECULAR BIOLOGY

Optical properties of amyloid stained by Congo red: History and mechanisms

(2008) Alexander J. Howie et al.   MICRON